|Videos|March 25, 2022
Considerations for Moderna's move to get an EUA for the COVID-19 vaccine in young kids
Author(s)Miranda Hester
Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.
Advertisement
Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
CDC-backed surveillance finds 4 in 5 child deaths preventable across 7 high-mortality countries
2
Vosoritide improves growth velocity in children with hypochondroplasia, phase 3 trial shows
3
Abbott launches first ready-to-feed whole milk infant formula in the U.S.
4
Semaglutide improves BMI category in children aged 6 to 11 years in phase 3 trial
5